Search results
Results From The WOW.Com Content Network
Chemotherapy agents, usually prescribed to treat cancer, especially when multiple drugs are used or they are in high dose. Severe hair loss is reported from doxorubicin, the nitrosoureas, and cyclophosphamide. Other causes are bleomycin, dactinomycin, daunorubicin, systemic fluorouracil, and high-dose methotrexate.
There are a number of conditions that may cause non scarring hair loss and the first step is to determine the pattern: focal or diffuse. [3] The next step is to identify if the hair loss is scarring or non scarring. A history and physical examination is necessary as this will provide clues to the ultimate diagnosis. It is essential to ask about ...
Areas of hair loss, usually on the scalp [7] Usual onset: Childhood [7] Causes: Autoimmune [7] Risk factors: Family history, female sex, rheumatoid arthritis, type 1 diabetes, celiac disease [7] [8] [9] Differential diagnosis: Trichotillomania, alopecia mucinosa, postpartum alopecia [1] Treatment: Sunscreen, head coverings to protect from sun ...
Alopecia totalis is the loss of all hair on the head and face.Its causes are unclear, but believed to be autoimmune.Research suggests there may be a genetic component linked to developing alopecia totalis; the presence of DRB1*0401 and DQB1*0301, both of which are human leukocyte antigens (HLA), were found to be associated with long-standing alopecia totalis.
Minoxidil is an effective, FDA-approved treatment for hair loss. But to recap, here’s what you need to know about potential Rogaine interactions: Like any medication, minoxidil can interact with ...
[3] [4] Causes of hair loss that occurs with scarring or inflammation include fungal infection, lupus erythematosus, radiation therapy, and sarcoidosis. [3] [4] Diagnosis of hair loss is partly based on the areas affected. [4] Treatment of pattern hair loss may simply involve accepting the condition, which can also include shaving one's head. [4]
The oral finasteride treatment led to an improvement in male pattern hair loss for 91.5 percent of the men and prevention of further hair loss for 99.1 percent. We like those odds. And there’s ...
However, the main side effect is increased risk of cutaneous atrophy at the site of treatment; [8] folliculitis is also an occasional complication. [9] Janus kinase inhibitors, previously used in the treatment of cancer and other diseases, such as arthritis, have successfully shown to be effective in the initial trials of treatment for alopecia ...